Andrew Neil1. Show Affiliations » 1. Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, The Churchill Hospital, Oxford, UK. andrew.neil@public-health.oxford.ac.uk
Abstract
Entities: Disease
Mesh： See more » Cost of IllnessDiabetes Mellitus, Type 2/mortalityDiabetes Mellitus, Type 2/prevention & controlDiabetic Angiopathies/mortalityDiabetic Angiopathies/prevention & controlDrug CombinationsHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHyperglycemia/prevention & controlHyperlipidemias/prevention & controlHypertension/prevention & controlInsulin ResistanceMorbidityRisk Factors
Substances： See more » Drug CombinationsHydroxymethylglutaryl-CoA Reductase Inhibitors
Year: 2003 PMID： 14984017 DOI： 10.1046/j.1462-8902.2003.0311.x
Source DB: PubMed Journal: Diabetes Obes Metab ISSN： 1462-8902 Impact factor: 6.577